Idexx Laboratories: Piper Sandler maintains overweight rating. Price target up to $600 from $500.
https://www.marketscreener.com/quote/stock/IDEXX-LABORATORIES-INC-9641/
Idexx Laboratories: Piper Sandler maintains overweight rating. Price target up to $600 from $500.
https://www.marketscreener.com/quote/stock/IDEXX-LABORATORIES-INC-9641/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.